Smoking Cessation for the Incarcerated: Why Prisons Are Tobacco Control's Final Frontier
Smoking rates in prisons are up to four times the general population rate. Most prisons have banned smoking—but bans don't treat addiction. What does justice-appropriate cessation look like?
In a medium-security prison in the American Midwest, a 38-year-old man serving a five-year sentence wakes at 6 AM to the familiar, gnawing need for nicotine. He's been a smoker since age 14—two packs a day by the time he was arrested. The prison banned tobacco in 2015. Officially, he hasn't smoked in three years. Unofficially, he trades commissary items for loose cigarettes smuggled in by visitors or corrupt staff, paying roughly ten times the street price per cigarette. He's tried to quit multiple times. The prison offers no cessation support—no patches, no gum, no counseling. The official policy is prohibition. The reality is a thriving black market, an untreated addiction, and a population that will re-enter society more dependent on nicotine, not less, than when it was incarcerated.
Prison populations smoke at rates vastly exceeding the general population—typically 50–75% compared to 10–15% in most developed countries—reflecting the overrepresentation of marginalized, low-income, and mentally ill populations in the criminal justice system, all of which have disproportionately high smoking rates. When smoking is banned in prisons, as it has been in most U.S. state and federal facilities, the UK, Canada, Australia, and New Zealand, the policy eliminates legal access without eliminating demand. The predictable result is an illicit economy where tobacco becomes a form of currency, generating the same dynamics—violence, corruption, wealth-based access inequity—that characterize prohibited markets everywhere. Guards become dealers. Visitation becomes a smuggling opportunity. And the addiction that contributed to the circumstances of incarceration goes untreated.
The health consequences are both acute and chronic. In the short term, forced nicotine withdrawal among incarcerated populations—who already have high rates of mental illness, including depression, anxiety, and PTSD—can exacerbate psychiatric symptoms precisely when access to mental health care is most limited. The irritability, anxiety, and cognitive disruption of withdrawal can contribute to disciplinary infractions, conflict with other incarcerated individuals, and self-harm. In the long term, smoking-related diseases—cardiovascular disease, COPD, cancer—are among the leading causes of death among formerly incarcerated populations, who already have dramatically reduced life expectancies. Returning citizens leave prison with an untreated nicotine addiction and re-enter communities where tobacco is legal, cheap, and heavily marketed. The relapse rate approaches 100%.
Some correctional systems have implemented more humane approaches. The UK's National Health Service provides NRT to incarcerated individuals as part of a comprehensive smoke-free prisons policy that was phased in gradually, with staff training, advance notice, and ongoing support. Canada's Correctional Service offers smoking cessation programs that include pharmacotherapy and counseling, recognizing that incarceration presents both a health risk (untreated addiction in a high-stress environment) and a health opportunity (a captive population that can access intensive cessation support). These programs are not acts of generosity toward people who have committed crimes. They're evidence-based public health interventions targeting a population with extreme health disparities, delivered in a setting where the state has assumed near-total control over the individual's environment—and therefore near-total responsibility for their health.
The opposition to providing cessation support in prisons comes from two directions. Some members of the public, and the politicians who represent them, object on the grounds that convicted criminals don't 'deserve' healthcare resources that could go to law-abiding citizens—a position that is legally at odds with the constitutional requirement to provide adequate medical care to incarcerated populations (upheld by the U.S. Supreme Court in *Estelle v. Gamble*, 1976) and ethically at odds with the principle that healthcare is a human right, not a reward for good behavior. Others object on practical grounds, arguing that nicotine patches and gum will be misused, traded, or abused. This is likely true, to some degree, but it's also true of every medication distributed in correctional settings, and it hasn't prevented prisons from providing antidepressants, antipsychotics, or pain medication. The operational challenges are real and manageable. The principled objection is neither.
The re-entry dimension adds urgency to the policy question. The vast majority of incarcerated individuals will eventually be released, and their health status upon release affects not only their own outcomes but the health of the communities they return to and the public systems that serve them. A person who leaves prison with an untreated nicotine addiction is highly likely to resume smoking, develop smoking-related disease, and ultimately require expensive medical care that's disproportionately funded by public insurance. Investing in prison-based cessation is not charity—it's cost-effective public health. A 2024 modeling study estimated that providing comprehensive cessation support in U.S. prisons would cost roughly $200 million annually and save approximately $1.5 billion in avoided healthcare costs over 20 years. The return on investment is not marginal. It's dramatic.
Prisons are tobacco control's final frontier not because the problem is intractable but because the political will to address it has been absent. It's easier to ban tobacco and declare victory than to implement the harm reduction infrastructure—counseling, pharmacotherapy, nicotine alternatives—that would actually treat addiction in a confined population. The result is a policy that looks tough and is functionally negligent: a ban that creates a black market, withdrawal that exacerbates mental illness, and a discharge pipeline that returns untreated addicts to society. A just correctional health system would treat nicotine dependence the same way it treats (or should treat) other substance use disorders: with evidence-based pharmacotherapy, behavioral support, and a harm-reduction framework that acknowledges that forced abstinence without support is not treatment. The question isn't whether incarcerated people deserve help quitting smoking. The question is whether the state, having taken away their liberty, has accepted responsibility for their health. Under any coherent theory of justice, it has.












